Related Experiment Video
Updated: Dec 6, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Novel coronavirus disease in patients with end-stage kidney disease
Noriaki Shimada1, Hiroaki Shimada2, Yoshiaki Itaya1
1Medical Corporation JISEIKAI Tachibana Clinic, Tokyo, Japan.
Insights
Patients with end-stage kidney disease on hemodialysis face a higher risk of novel coronavirus disease (COVID-19) infection and mortality. Rapid implementation of preventive measures in dialysis facilities is crucial to mitigate spread.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic, originating in Wuhan, China, poses a significant threat globally.
- End-stage kidney disease patients undergoing hemodialysis (HD) are a vulnerable population with increased infection risk.
- Comorbidities common in renal failure, like hypertension and cardiovascular disease, exacerbate COVID-19 severity and mortality.
Purpose of the Study:
- To review the latest findings on COVID-19 in patients with end-stage kidney disease.
- To summarize current global guidelines for preventing COVID-19 spread in dialysis facilities.
Main Methods:
- Literature review of recent studies on COVID-19 in end-stage kidney disease patients.
- Compilation and analysis of international guidelines for infection control in dialysis settings.
Main Results:
- Dialysis patients exhibit significantly higher morbidity and mortality rates from COVID-19 compared to the general population.
- No specific treatments for COVID-19 are currently available, emphasizing the need for prevention.
Conclusions:
- Urgent establishment of effective countermeasures in dialysis facilities is essential to protect this high-risk group.
- Proactive infection control strategies are critical for managing COVID-19 in end-stage kidney disease patients undergoing HD.
Abstract:
The novel coronavirus disease outbreak started in Wuhan, China, in December 2019 and has since spread rapidly worldwide. As almost all patients with end-stage kidney disease have been treated with HD in Japan, they have a higher risk of infection than the healthy population. Moreover, the complications of renal failure, such as hypertension and cardiovascular diseases, appear to be a risk factor of death owing to novel coronavirus disease. The reported morbidity and mortality rates of novel coronavirus disease are significantly higher in dialysis patients than in the healthy population. No treatment for novel coronavirus disease has yet been developed; thus, countermeasures to prevent the spread of coronavirus disease in dialysis facilities must be rapidly established. The latest findings on novel coronavirus disease in patients with end-stage kidney disease and the guidelines for countermeasures against the spread of novel coronavirus disease worldwide are summarized in this review.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

